Can anyone buy Wegovy, or is it only for certain people?

The myth: 'It's freely available online if you know where to look'

This is probably the most common misconception our prescribers hear. Because Wegovy has received a great deal of press attention and because plenty of websites appear to offer it at a click, many people assume the clinical gate can be bypassed. It cannot, legally or safely.

Wegovy (semaglutide) is licensed for weight management in the UK under strict criteria, and the Human Medicines Regulations 2012 make it a Prescription-Only Medicine. A prescriber must assess you personally before any legitimate pharmacy dispenses it. Sellers offering it without a prescription are operating illegally, and the product they send is extremely unlikely to be genuine.

The MHRA has warned publicly about counterfeit weight-loss pens circulating through social media and unregistered websites. In October 2025 enforcement teams raided the first illicit UK manufacturing site producing fake tirzepatide pens, and earlier seizures across 2025 amounted to roughly 20 million doses with an estimated street value of £45 million. Fake pens have contained insulin in some cases, which has led to hospitalisations. The warning signs are consistent: no requirement to see a clinician, prices far below the market rate, and sellers operating solely through social platforms. If you are trying to find where you can buy Wegovy near you, it is worth understanding those warning signs before searching, so you can immediately rule out any seller that displays them. If you spot a suspect seller, report them via the MHRA's Yellow Card scheme.

Who Wegovy is actually licensed for in the UK

NICE recommended semaglutide for weight management (TA875) for adults with a BMI of 35 or above and at least one weight-related health condition, used for a maximum of two years within a specialist weight management service. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. The medicine's licence itself is broader: adults with a BMI of 30 or above, or a BMI of 27 or above alongside a weight-related condition such as high blood pressure, type 2 diabetes or high cholesterol.

Private prescribing follows the licensed criteria rather than the narrower NICE recommendation, which is why a private route can be available to people who do not meet the NHS threshold or who would face a long wait on a specialist list. Either way, a prescriber makes the final call. BMI alone is never the whole picture; your medical history, current medicines and other factors all feed into the assessment. You can explore who typically qualifies in more detail on the Wegovy treatment overview.

Wegovy is not recommended during pregnancy, while breastfeeding, or for anyone trying to conceive. It is not licensed for people under 18. A history of certain conditions, including pancreatitis or medullary thyroid carcinoma, requires careful prescriber discussion before any GLP-1 medicine is considered. The NICE technology appraisal TA875 sets out the full clinical criteria.

How to get Wegovy through a legitimate, verifiable route

The only safe path starts with a clinical consultation. For a private route, that means an online pharmacy registered with the General Pharmaceutical Council (GPhC) and staffed by a prescriber who can issue a private prescription.

Checking legitimacy is straightforward. Every registered UK pharmacy has a GPhC premises number you can verify at pharmacyregulation.org/registers. If a website does not display one, or you cannot find the number on the register, stop there. nume's registration number is 9012878, verifiable directly on the GPhC site.

At nume, the process runs like this: you complete a free consultation online; a GPhC-registered Independent Prescriber reviews your answers the same day, a real clinician reads your case, not an algorithm. Your identity and current weight are verified before any prescription is issued, and your GP is notified in line with GPhC guidance. If you are approved and order before midday, treatment is dispatched the same afternoon. You can find out more about buying Wegovy online safely, or read about which prescribers can issue a Wegovy prescription if you want to understand your options more fully.

The NHS route exists too, though availability is limited. Wegovy is available through specialist weight management services under TA875, and waiting lists in many areas are long. Details of where availability currently stands are covered on the Wegovy UK availability page. If you want to explore whether a private consultation is right for you, start your free consultation with our prescribers.

What to watch for when comparing private providers

Not all private providers operate the same way, and the differences matter for a prescription medicine. Some charge separately for the consultation, the prescription and the delivery; others bundle everything. Some use asynchronous prescribing with no real-time verification; others, like nume, include live weight verification and ID checks before issuing a prescription.

For transfer patients or anyone requesting a dose increase, evidence of your current treatment should be required by a responsible provider, that check protects you as much as it protects the prescriber. A question our prescribers hear most weeks is whether a previous prescription from another service counts as proof of suitability. The short answer is that clinical re-review is still needed; it is not a rubber stamp, but it is usually straightforward if your records are in order.

Price varies across providers, and it is worth knowing that Eli Lilly raised Mounjaro's UK list price substantially from September 2025, which pulled the broader GLP-1 market upward. Typical private prices for Wegovy now range roughly £149–£375 per month depending on dose and provider, as widely reported. What those headline figures include differs. On the Wegovy payment and where-to-buy page you will find a breakdown of what to check. For broader context on available weight-loss treatments, the weight-loss treatments overview lays out the full picture.